Khanh Thi My Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Khanh Thi My Tran has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Thanh Duc Nguyen
Department of Biomedical Engineering, University of Connecticut, Storrs, USA
3 shared publications - Thinh T. Le
Department of Mechanical Engineering, University of Connecticut, Storrs, CT 06269, USA
3 shared publications - Ana Jaklenec
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
2 shared publications - Ritopa Das
Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, USA
2 shared publications - Robert Langer
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
2 shared publications - Tra Vinikoor
Department of Biomedical Engineering, University of Connecticut, Storrs, CT 06269, USA
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Springer Nature in Nature Biotechnology
- p. 1-10
Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI
- 28 September 2026
- Published by Springer Nature in Nature Biotechnology
- p. 1-10
Open AccessAccelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI
- Top Cited PapersOpen Access
- 24 February 2025
- Published by Springer Nature in Nature Materials
- Vol. 24 (5) , 794-803
On-patient medical record and mRNA therapeutics using intradermal microneedles
Medical interventions often require timed series of doses, thus necessitating accurate medical record-keeping. In many global settings, these records are unreliable or unavailable at the point of care, leading to less effective treatments or disease prevention. Here we present an invisible-to-the-naked-eye on-patient medical record-keeping technology that accurately stores medical information in the patient skin as part of microneedles that are used for intradermal therapeutics. We optimize the microneedle design for both a reliable delivery of messenger RNA (mRNA) therapeutics and the near-infrared fluorescent microparticles that encode the on-patient medical record-keeping. Deep learning-based image processing enables encoding and decoding of the information with excellent temporal and spatial robustness. Long-term studies in a swine model demonstrate the safety, efficacy and reliability of this approach for the co-delivery of on-patient medical record-keeping and the mRNA vaccine encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This technology could help healthcare workers make informed decisions in circumstances where reliable record-keeping is unavailable, thus contributing to global healthcare equity.
- 24 February 2025
- Published by Springer Nature in Nature Materials
- Vol. 24 (5) , 794-803
Top Cited PapersOpen AccessOn-patient medical record and mRNA therapeutics using intradermal microneedles
Medical interventions often require timed series of doses, thus necessitating accurate medical record-keeping. In many global settings, these records are unreliable or unavailable at the point of care, leading to less effective treatments or disease prevention. Here we present an invisible-to-the-naked-eye on-patient medical record-keeping technology that accurately stores medical information in the patient skin as part of microneedles that are used for intradermal therapeutics. We optimize the microneedle design for both a reliable delivery of messenger RNA (mRNA) therapeutics and the near-infrared fluorescent microparticles that encode the on-patient medical record-keeping. Deep learning-based image processing enables encoding and decoding of the information with excellent temporal and spatial robustness. Long-term studies in a swine model demonstrate the safety, efficacy and reliability of this approach for the co-delivery of on-patient medical record-keeping and the mRNA vaccine encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This technology could help healthcare workers make informed decisions in circumstances where reliable record-keeping is unavailable, thus contributing to global healthcare equity.
- Top Cited PapersOpen Access
- 16 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (24) , eadg6075
Highly piezoelectric, biodegradable, and flexible amino acid nanofibers for medical applications
Amino acid crystals are an attractive piezoelectric material as they have an ultrahigh piezoelectric coefficient and have an appealing safety profile for medical implant applications. Unfortunately, solvent-cast films made from glycine crystals are brittle, quickly dissolve in body fluid, and lack crystal orientation control, reducing the overall piezoelectric effect. Here, we present a material processing strategy to create biodegradable, flexible, and piezoelectric nanofibers of glycine crystals embedded inside polycaprolactone (PCL). The glycine-PCL nanofiber film exhibits stable piezoelectric performance with a high ultrasound output of 334 kPa [under 0.15 voltage root-mean-square (Vrms)], which outperforms the state-of-the-art biodegradable transducers. We use this material to fabricate a biodegradable ultrasound transducer for facilitating the delivery of chemotherapeutic drug to the brain. The device remarkably enhances the animal survival time (twofold) in mice-bearing orthotopic glioblastoma models. The piezoelectric glycine-PCL presented here could offer an excellent platform not only for glioblastoma therapy but also for developing medical implantation fields.
- 16 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (24) , eadg6075
Top Cited PapersOpen AccessHighly piezoelectric, biodegradable, and flexible amino acid nanofibers for medical applications
Amino acid crystals are an attractive piezoelectric material as they have an ultrahigh piezoelectric coefficient and have an appealing safety profile for medical implant applications. Unfortunately, solvent-cast films made from glycine crystals are brittle, quickly dissolve in body fluid, and lack crystal orientation control, reducing the overall piezoelectric effect. Here, we present a material processing strategy to create biodegradable, flexible, and piezoelectric nanofibers of glycine crystals embedded inside polycaprolactone (PCL). The glycine-PCL nanofiber film exhibits stable piezoelectric performance with a high ultrasound output of 334 kPa [under 0.15 voltage root-mean-square (Vrms)], which outperforms the state-of-the-art biodegradable transducers. We use this material to fabricate a biodegradable ultrasound transducer for facilitating the delivery of chemotherapeutic drug to the brain. The device remarkably enhances the animal survival time (twofold) in mice-bearing orthotopic glioblastoma models. The piezoelectric glycine-PCL presented here could offer an excellent platform not only for glioblastoma therapy but also for developing medical implantation fields.
- 30 October 2022
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (3) , 2200905
A Single‐Administration Microneedle Skin Patch for Multi‐Burst Release of Vaccine against SARS‐CoV‐2
The necessity for multiple injections and cold‐chain storage has contributed to suboptimal vaccine utilization, especially in pandemic situations. Thermally‐stable and single‐administration vaccines hold a great potential to revolutionize the global immunization process. Here, a new approach to thermally stabilize protein‐based antigens is presented and a new high‐throughput antigen‐loading process is devised to create a single‐administration, pulsatile‐release microneedle (MN) patch which can deliver a recombinant SARS‐CoV‐2 S1‐RBD protein—a model for the COVID‐19 vaccine. Nearly 100% of the protein antigen could be stabilized at temperatures up to 100 °C for at least 1 h and at an average human body temperature (37 °C) for up to 4 months. Arrays of the stabilized S1‐RBD formulations can be loaded into the MN shells via a single‐alignment assembly step. The fabricated MNs are administered at a single time into the skin of rats and induce antibody response which could neutralize authentic SARS‐CoV‐2 viruses, providing similar immunogenic effect to that induced by multiple bolus injections of the same antigen stored in conventional cold‐chain conditions. The MN system presented herein could offer the key solution to global immunization campaigns by avoiding low patient compliance, the requirement for cold‐chain storage, and the need for multiple booster injections.
- 30 October 2022
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (3) , 2200905
A Single‐Administration Microneedle Skin Patch for Multi‐Burst Release of Vaccine against SARS‐CoV‐2
The necessity for multiple injections and cold‐chain storage has contributed to suboptimal vaccine utilization, especially in pandemic situations. Thermally‐stable and single‐administration vaccines hold a great potential to revolutionize the global immunization process. Here, a new approach to thermally stabilize protein‐based antigens is presented and a new high‐throughput antigen‐loading process is devised to create a single‐administration, pulsatile‐release microneedle (MN) patch which can deliver a recombinant SARS‐CoV‐2 S1‐RBD protein—a model for the COVID‐19 vaccine. Nearly 100% of the protein antigen could be stabilized at temperatures up to 100 °C for at least 1 h and at an average human body temperature (37 °C) for up to 4 months. Arrays of the stabilized S1‐RBD formulations can be loaded into the MN shells via a single‐alignment assembly step. The fabricated MNs are administered at a single time into the skin of rats and induce antibody response which could neutralize authentic SARS‐CoV‐2 viruses, providing similar immunogenic effect to that induced by multiple bolus injections of the same antigen stored in conventional cold‐chain conditions. The MN system presented herein could offer the key solution to global immunization campaigns by avoiding low patient compliance, the requirement for cold‐chain storage, and the need for multiple booster injections.
- Top Cited Papers
- 12 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (627) , eabi7282
Exercise-induced piezoelectric stimulation for cartilage regeneration in rabbits
A biodegradable piezoelectric scaffold excited by exercise promotes chondrogenesis and cartilage regeneration in rabbit osteochondral defects.
- 12 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (627) , eabi7282
Top Cited PapersExercise-induced piezoelectric stimulation for cartilage regeneration in rabbits
A biodegradable piezoelectric scaffold excited by exercise promotes chondrogenesis and cartilage regeneration in rabbit osteochondral defects.
- 10 May 2016
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 22 (19) , 2844-2856
Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles
Marine environment exhibits an enormous diversity of organisms which contains an abundant source of polysaccharides. As polymer matrix carriers, marine-based polymers possess several valuable properties including high stability, non-toxicity, hydrophilicity, biodegradability, with low production cost. Despite notable biological activities of these natural polymers, there are certain limitations in exploring their functions in applications of nano-sized drug delivery systems. The review aims to demonstrate exceptional characteristics of marine-based polymers including fucoidan, alginate, carrageenan, hyaluronic acid, chondroitin sulfate, and chitosan as well as provide perspectives of current publications on their nanoparticle formulations for biomedical applications.
- 10 May 2016
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 22 (19) , 2844-2856
Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles
Marine environment exhibits an enormous diversity of organisms which contains an abundant source of polysaccharides. As polymer matrix carriers, marine-based polymers possess several valuable properties including high stability, non-toxicity, hydrophilicity, biodegradability, with low production cost. Despite notable biological activities of these natural polymers, there are certain limitations in exploring their functions in applications of nano-sized drug delivery systems. The review aims to demonstrate exceptional characteristics of marine-based polymers including fucoidan, alginate, carrageenan, hyaluronic acid, chondroitin sulfate, and chitosan as well as provide perspectives of current publications on their nanoparticle formulations for biomedical applications.